Breast and Cervical Cancer Program definition

Breast and Cervical Cancer Program means the program administered by OHA for providing assistance to individuals needing treatment for breast or cervical cancer as such program is described in OAR 410-200-0400 and which makes use of Medicaid funds as authorized under the Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Sample 1Sample 2Sample 3
Breast and Cervical Cancer Program means the program administered by OHA for providing assistance to individuals needing treatment for breast or cervical cancer as such program is described in OAR 000-000-0000 and which makes use of Medicaid funds as authorized under the Breast and Cervical Cancer Prevention and Treatment Act of 2000.
Sample 1
Breast and Cervical Cancer Program means a local health department program for the early detection of breast and cervical cancer.]
Sample 1

Examples of Breast and Cervical Cancer Program in a sentence

  • As a cost reimbursed subgrant, costs incurred are reimbursed through the submission of invoices as instructed by Mississippi State Department of Health, Breast and Cervical Cancer Program.

  • Breast and Cervical Cancer Program (BCCP) services are matched at 65% FMAP.

  • Through support provided by the Centers for Disease Control, National Breast and Cervical Cancer Early Detection Program (NBCCEDP) and non-federal funding sources, the Mississippi Breast and Cervical Cancer Program (MS-BCCP) is a screening program that supports and promotes breast and cervical cancer screening for medically underserved women that are considered high risk.

  • Breast and Cervical Cancer Program (BCCP) services receive a 65%enhanced FMAP (69.34% during the COVID-19 Public Health Emergency); Family Planning Services receive a 90% FMAP; and Indian Health Services receive a 100% FMAP.

  • Amy Gibbons, Program Director Mississippi State Department of Health Breast and Cervical Cancer Program 570 E.

  • COVERED SERVICES The following services are eligible for reimbursement during an HPE period: • Low Income Families (Parents and Other Caretaker Relatives), Medicaid Children Under age 19, South Dakota Medicaid for Youth Formerly in Foster Care, Breast and Cervical Cancer Program, and Medicaid Expansion – Adult Group (Individuals Aged 19 or Older and Under Aged 65 At or Below 138% of the Federal Poverty Level) are eligible to receive all Medicaid covered services.

Related to Breast and Cervical Cancer Program

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • Treatment program means an abstinence based program or facility that is accredited by any of the following:

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Acid Rain Program means the sulfur dioxide and nitrogen oxides air pollution control program established pursuant to Title IV of the Act under 40 CFR Parts 72-78.

  • Opioid treatment program means a detoxification or maintenance treatment program which is required to report patient identifying information to the central registry and which is located in the state.

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Loan Program means the State Treasurer’s Interest-Free Loan Program for Colorado School Districts authorized pursuant to the Loan Program Statutes.

  • Modular home means a modular unit as defined in Section 15A-1-302.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Phase IV Clinical Trial means a Clinical Trial conducted after a Product achieves Regulatory Approval, carried out for the purposes of conducting safety surveillance and ongoing technical support of the Product.

  • Individualized education program or “IEP” means a written statement for a child with a disability as defined in 14 DE Admin. Code 922.